Kyphoscoliosis Treatment Global Market Report 2025
상품코드:1825432
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
척주 후만증치료 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 5.7%로 40억 5,000만 달러로 성장합니다. 예측 기간의 성장은 개인 맞춤형 치료 접근법, 생체역학 연구 확대, 원격 모니터링 및 원격의료 서비스, 지속적인 유전자 연구에 기인합니다. 예측 기간의 주요 동향으로는 첨단 수술 기술, 혁신적인 보조기 기술, 맞춤형 치료 계획, 3D 프린팅의 채택, 통증 관리의 혁신 등이 있습니다.
향후 5년간 성장률 5.7%라는 예측은 지난번 예측보다 0.1% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 부과는 스위스나 일본에서 수입되는 맞춤형 척수봉과 척추 고정 시스템에 대한 접근을 제한함으로써 미국에 심각한 문제를 야기할 수 있으며, 교정 수술을 방해하고 척수 치료 단가를 상승시킬 수 있습니다. 또한 상호 관세와 무역 긴장과 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
척추 손상 증가는 척추후만증 치료 시장의 확대를 촉진할 것으로 예측됩니다. 척수 손상이란 척추, 추간판, 인대, 근육, 신경, 기타 지지 구조물을 포함한 척추의 구성 요소에 대한 모든 손상, 외상, 위해를 말합니다. 척추 손상으로 인한 후만증 치료에는 정형외과적 평가, 물리치료, 보조기, 수술 가능성, 통증 관리, 환자 교육 및 개인별 맞춤 치료 계획에 중점을 둔 다학제적 의료팀 등의 종합적인 접근이 필요합니다. 예를 들어 미국 앨라배마 주정부 기관인 앨라배마 주 공중보건국에 따르면 2022년 2월 ATR은 2021년 4,734건 대비 2022년 3,817건의 머리와 척수를 포함한 신경학적인 손상을 보고했습니다. 그 결과, 척추 손상 증가는 척추후만증 치료 시장의 성장을 가속하고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 척주 후만증치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 척주 후만증치료 시장 : 성장률 분석
세계의 척주 후만증치료 시장 실적 : 규모와 성장, 2019-2024년
세계의 척주 후만증치료 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 척주 후만증치료 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 척주 후만증치료 시장 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
자세성 척주 후만증
슈어만 척주 후만증
선천성 척주 후만증
세계의 척주 후만증치료 시장 : 치료별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
의약품
수술·장구
세계의 척주 후만증치료 시장 : 최종사용자별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
병원
클리닉
외래 수술 센터
세계의 척주 후만증치료 시장 : 서브 세분화 자세성 척주 후만증(유형별), 실적과 예측, 2019-2024년, 2024-2029년, 2034년
사춘기 자세성 척주 후만증
성인 자세성 척주 후만증
세계의 척주 후만증치료 시장 : 서브 세분화 슈어만 척주 후만증, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
사춘기 슈어만 척주 후만증
성인 슈어만 척주 후만증
세계의 척주 후만증치료 시장 : 서브 세분화 선천성 척주 후만증(유형별), 실적과 예측, 2019-2024년, 2024-2029년, 2034년
유형 I 선천성 척주 후만증
유형 II 선천성 척주 후만증
기타 선천성
제7장 지역별·국가별 분석
세계의 척주 후만증치료 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 척주 후만증치료 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
척주 후만증치료 시장 : 경쟁 구도
척주 후만증치료 시장 : 기업 개요
Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
Aspen Medical Products LLC Overview, Products and Services, Strategy and Financial Analysis
Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
Milwaukee Brace Company Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Zimmer Biomet Holdings Inc.
Perrigo Company plc
Teva Pharmaceuticals Inc.
B. Braun Melsungen Aktiengesellschaft
Aurobindo Pharma Limited
Integra LifeSciences Ltd.
NuVasive Inc.
DJO Global Inc.
Globus Medical Inc.
Boston Orthotics & Prosthetics
Ossur hf.
Aesculap Inc.
DeRoyal Industries Inc.
MicroPort Scientific Corp.
Alphatec Holdings Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
척주 후만증치료 시장 2029년 : 새로운 기회를 제공하는 국가
척주 후만증치료 시장 2029년 : 새로운 기회를 제공하는 부문
척주 후만증치료 시장 2029년 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Kyphoscoliosis is a spinal condition characterized by abnormal forward curvature (kyphosis) and sideways curvature (scoliosis) of the spine, leading to postural and respiratory problems. The treatment involves medical interventions and therapies aimed at managing and correcting the spinal deformity, improving posture, reducing pain, and preventing further spinal curvature.
The main types of kyphoscoliosis include postural kyphosis, Scheuermann's kyphosis, congenital kyphosis, and kyphoscoliosis. Postural kyphosis refers to the rounding or hunching of the back, typically affecting teenagers and young adults. Treatment options for kyphoscoliosis encompass medications, surgery, and bracing, and these are implemented by hospitals, clinics, and ambulatory surgical centers.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The kyphoscoliosis treatment market research report is one of a series of new reports from The Business Research Company that provides kyphoscoliosis treatment market statistics, including kyphoscoliosis treatment industry global market size, regional shares, competitors with a kyphoscoliosis treatment market share, detailed kyphoscoliosis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the kyphoscoliosis treatment industry. This kyphoscoliosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The kyphoscoliosis treatment market size has grown strongly in recent years. It will grow from $3.08 billion in 2024 to $3.25 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to exploration of regenerative medicine, genetic research contributions, telemedicine and remote monitoring, advancements in rehabilitation programs.
The kyphoscoliosis treatment market size is expected to see strong growth in the next few years. It will grow to $4.05 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to personalized treatment approaches, expansion of biomechanical research, remote monitoring and telehealth services, continued genetic research. Major trends in the forecast period include advanced surgical techniques, innovative bracing technologies, customized treatment plans, adoption of 3D printing, pain management innovations.
The forecast of 5.7% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for the U.S. by restricting access to custom spinal rods and vertebral body tethering systems imported from Switzerland and Japan, potentially compromising corrective surgeries and increasing spinal care unit costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growing number of spinal cord injuries is anticipated to drive the expansion of the kyphoscoliosis treatment market. Spinal cord injuries refer to any damage, trauma, or harm to the spine's components, including the vertebrae, intervertebral discs, ligaments, muscles, nerves, and other supportive structures, which can lead to the development of kyphoscoliosis and alterations in spinal alignment. Treating kyphoscoliosis caused by spinal cord injuries involves a holistic approach, including orthopedic evaluation, physical therapy, bracing, possible surgery, pain management, and a multidisciplinary healthcare team focused on patient education and personalized care plans. For example, in February 2022, according to the Alabama Department of Public Health, a US-based state agency, the ATR reported 3,817 neurological injuries involving the head and spinal cord in 2022, compared to 4,734 cases in 2021. As a result, the increasing number of spinal cord injuries is fueling the growth of the kyphoscoliosis treatment market.
The rise in telemedicine usage is expected to further drive the growth of the kyphoscoliosis treatment market. Telemedicine refers to healthcare services delivered remotely through telecommunications technologies, such as videoconferencing, phone calls, and digital messaging. It enables patients to consult with orthopedic specialists and spine surgeons without needing to travel to healthcare facilities, which is particularly beneficial for individuals with kyphoscoliosis who may face physical challenges. For example, in February 2023, Rock Health, a US-based non-profit, reported that 80% of survey respondents had used telemedicine at some point in 2022, up from 72% in 2021. Thus, the increased use of telemedicine is contributing to the growth of the healthcare transportation service market.
The increasing incidence of genetic disorders is expected to be a significant catalyst for the growth of the kyphoscoliosis treatment market. Genetic disorders, stemming from abnormalities or mutations in an individual's DNA, often involve spinal curvature abnormalities requiring kyphoscoliosis treatment. The prevalence of genetic conditions in children is estimated to be 1 in 25 in the UK, affecting over 2.4 million individuals. The multidisciplinary treatment approach, encompassing various strategies such as beta-blocker therapy, physical therapy, and orthopedic surgeon supervision, underlines the pivotal role of kyphoscoliosis treatment in managing genetic disorders and contributes to market growth.
Leading companies in the kyphoscoliosis treatment market are developing innovative products, such as the MARVEL Growing Rod System, specifically designed for early-onset scoliosis. The MARVEL Growing Rod System is a posterior stabilizing rod that can be surgically implanted and periodically lengthened through hand-operated mechanical actuation. For example, in July 2023, Globus Medical Inc., a US-based medical device company, launched the MARVEL Growing Rod System. It is designed to assist patients under 10 years old with early-onset scoliosis in achieving and maintaining spinal correction while allowing for continued growth through minimally invasive distraction. The system offers significant distraction, immediate tactile feedback, and automated locking, ensuring reliable growth. This innovative product, the Growing Rod System, is expected to contribute to the future growth of the market.
Major companies operating in the kyphoscoliosis treatment market report are Johnson & Johnson Services Inc., Aspen Medical Products LLC, Medtronic PLC, Stryker Corporation, Milwaukee Brace Company, Zimmer Biomet Holdings Inc., Perrigo Company PLC, Teva Pharmaceuticals Inc., B. Braun Melsungen Aktiengesellschaft, Aurobindo Pharma Limited, Integra LifeSciences Ltd., NuVasive Inc., DJO Global Inc., Globus Medical Inc., Boston Orthotics & Prosthetics, Ossur hf., Aesculap Inc., DeRoyal Industries Inc., MicroPort Scientific Corp., Alphatec Holdings Inc., Trulife Ltd., Ottobock SE & Co. KGaA, Orthofix Holdings Inc., OrthoPediatrics Corp., Proteor S.A., Orthomerica Products Inc., Breg Inc., Innomed Inc., Restorative Care of America Inc., Spinal Elements Inc.
North America was the largest region in the kyphoscoliosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kyphoscoliosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the kyphoscoliosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The kyphoscoliosis treatment market consists of revenues earned by entities by providing services such as physical therapy, pain management, specialist psychological support, and medical evaluation. The market value includes the value of related goods sold by the service provider or included within the service offering. The kyphoscoliosis treatment market also includes sales of lumbar support cushions, orthopedic braces, back support belts, and exercise and therapy equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Kyphoscoliosis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on kyphoscoliosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for kyphoscoliosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The kyphoscoliosis treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Postural Kyphosis; Scheuermann's Kyphosis; Congenital Kyphosis
2) By Treatment: Medications; Surgery And Bracing
3) By End-User: Hospital; Clinics; Ambulatory Surgical Centers
Subsegments:
1) By Postural Kyphosis: Adolescent Postural Kyphosis; Adult Postural Kyphosis
2) By Scheuermann's Kyphosis: Adolescent Scheuermann's Kyphosis; Adult Scheuermann's Kyphosis
3) By Congenital Kyphosis: Type I Congenital Kyphosis; Type II Congenital Kyphosis; Other Congenital Forms
Companies Mentioned: Johnson & Johnson Services Inc.; Aspen Medical Products LLC; Medtronic plc; Stryker Corporation; Milwaukee Brace Company; Zimmer Biomet Holdings Inc.; Perrigo Company plc; Teva Pharmaceuticals Inc.; B. Braun Melsungen Aktiengesellschaft; Aurobindo Pharma Limited; Integra LifeSciences Ltd.; NuVasive Inc.; DJO Global Inc.; Globus Medical Inc.; Boston Orthotics & Prosthetics; Ossur hf.; Aesculap Inc.; DeRoyal Industries Inc.; MicroPort Scientific Corp.; Alphatec Holdings Inc.; Trulife Ltd.; Ottobock SE & Co. KGaA; Orthofix Holdings Inc.; OrthoPediatrics Corp.; Proteor S.A.; Orthomerica Products Inc.; Breg Inc.; Innomed Inc.; Restorative Care of America Inc.; Spinal Elements Inc.
3. Kyphoscoliosis Treatment Market Trends And Strategies
4. Kyphoscoliosis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Kyphoscoliosis Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Kyphoscoliosis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Kyphoscoliosis Treatment Market Growth Rate Analysis
5.4. Global Kyphoscoliosis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Kyphoscoliosis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Kyphoscoliosis Treatment Total Addressable Market (TAM)
6. Kyphoscoliosis Treatment Market Segmentation
6.1. Global Kyphoscoliosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Postural Kyphosis
Scheuermann's Kyphosis
Congenital Kyphosis
6.2. Global Kyphoscoliosis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medications
Surgery And Bracing
6.3. Global Kyphoscoliosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital
Clinics
Ambulatory Surgical Centers
6.4. Global Kyphoscoliosis Treatment Market, Sub-Segmentation Of Postural Kyphosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adolescent Postural Kyphosis
Adult Postural Kyphosis
6.5. Global Kyphoscoliosis Treatment Market, Sub-Segmentation Of Scheuermann's Kyphosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adolescent Scheuermann's Kyphosis
Adult Scheuermann's Kyphosis
6.6. Global Kyphoscoliosis Treatment Market, Sub-Segmentation Of Congenital Kyphosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Type I Congenital Kyphosis
Type II Congenital Kyphosis
Other Congenital Forms
7. Kyphoscoliosis Treatment Market Regional And Country Analysis
7.1. Global Kyphoscoliosis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Kyphoscoliosis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
